NASDAQ:MNPR | Cash Flow Statement | Monopar Therapeutics

Complete source-backed cash-flow history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.31M
2026-03-31-$3.89M-$3.47M-$5.58M-$200,203.00
2025-12-31-$5.2M-$3.37M-$62.19M$0.00-$384,680.00
2025-09-30-$3.44M
2025-06-30-$2.45M
2025-03-31-$2.62M-$5.66M-$325,828.00-$115,682.00
2024-12-31-$10.93M-$2M-$14.34M$0.00$56.14M
2024-09-30-$1.3M
2024-06-30-$1.72M
2024-03-31-$1.64M-$1.66M-$983,307.00$3.18M
2023-12-31-$1.81M-$1.55M$2.97M$334,548.00
2023-09-30-$1.95M
2023-06-30-$2.2M
2023-03-31-$2.43M-$2.27M-$983,443.00$804,798.00
2022-12-31-$2.9M-$1.3M-$4.92M$138,737.00
2022-09-30-$2.4M
2022-06-30-$2.76M
2022-03-31-$2.46M-$2.47M$0.00-$16,666.00
2021-12-31-$2.68M-$2.03M-$7,772.00
2021-09-30-$2.46M
2021-06-30-$2.08M
2021-03-31-$1.88M-$1.94M$10.92M
2020-12-31-$2.13M-$1.24M-$7,140.00
2020-09-30-$1.64M
2020-06-30-$1.45M
2020-03-31-$1.09M-$1.13M$508,044.00
2019-12-31-$1.21M-$668,705.00$9.39M
2019-09-30-$736,080.00
2019-06-30-$905,700.00
2019-03-31-$1.38M-$995,972.00-$13,855.00
2018-12-31-$890,461.00-$519,212.00-$206,270.00
2018-09-30-$640,184.00
2018-06-30-$640,184.00
2018-03-31-$876,347.00-$808,849.00$0.00
2017-12-31-$713,583.00-$816,021.00$10,001.00
2017-09-30-$14.88M
2017-06-30-$591,438.00
2017-03-31-$372,915.00-$311,486.00$990,002.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$13.72M-$12.2M-$63.45M$35M$91.57M
2024-12-31-$15.59M-$6.4M-$14.34M$0.00$59.29M
2023-12-31-$8.4M-$7.86M$4.93M$2.03M
2022-12-31-$10.52M-$7.23M-$4.92M$32,873.00
2021-12-31-$9.1M-$7.32M$0.00$10.88M
2020-12-31-$6.3M-$4.66M$8.18M
2019-12-31-$4.22M-$3.02M$9.35M
2018-12-31-$3.23M-$2.68M-$206,270.00
2017-12-31-$16.55M-$2.63M$9.54M
2016-12-31-$1.19M-$1.19M$1.26M